December 7, 2021
Online event - joining instructions will be sent to registrants by email.
Be inspired by the deep tech innovations from our community of startups, industry & academia who are using science and engineering to develop technologies with the power to transform global challenges that face our planet.
This event was meant to be in-person at Scale Space White City. However due to the uncertainty of the impact of the new Omnicron variant, we are moving it online. We thank Scale Space for their support and look forward to hosting a DTN in-person at their fabulous venue in 2022.
White City’s Innovation District is a growing hub for life sciences, and a hotbed of disruptive and ambitious engineering, involving the world-leading Imperial College London, tech and science startups.
We have an incredible line-up of talks including:
Anne Roques (Translation Project Manager, MSk Accelerator) & Lance Rane (CEO & Co-founder, Biomex) , Faculty of Engineering Imperial College London – Anne provides industry-inspired product development support to translational projects, selected through an established process (including a review by a panel of MedTech experts). The projects greatly benefit from the Industrial Partnership and Commercialisation team’s advice and the translation culture at Imperial College. The support provided includes an ISO13485 certified Quality Management System, for the design and development of medical devices, and a tailored project management function.
Lance is a medical doctor who worked in the NHS and elsewhere for several years before switching to engineering. After his PhD in the the department of Bioengineering, he founded Biomex, an Imperial spin-out, to commercialise his research combining neuromuscular electrical stimulation and AI. Biomex is developing wearable devices for patients with osteoarthritis and athletes following sports injury.
Dr Francesco A. Aprile, Faculty of Natural Sciences, Department of Chemistry at Imperial College London – The Aprile Lab’s research focuses on the development of biomolecules (molecules that are produced by living organisms) as research tools to understand disease mechanisms and for clinical applications. In particular, they are investigating proteins and antibodies that can help them to understand why proteins aggregate in the brain and lead to many forms of dementia.
Nicolas Moser, Co-Founder and CTO at ProtonDx – Spun out of Imperial College London in March 2020, ProtonDx is revolutionising the world of diagnostic tests. They have developed a microchip based rapid diagnostic technology for infectious diseases. The device can also tag results and upload them to a cloud-based system to monitor disease progression and track outbreaks. They have recently adapted the technology to test for COVID-19 which provides quantitative results to a smartphone app in under 20 minutes.
Thomas Antalffy, Founder and CEO at Smart Respiratory – A digital healthcare company based in Imperial White City Incubator. Smart Respiratory’s Smart Peak Flow meter turns a smartphone into a handy personal asthma assistant. By properly tracking an asthmatic’s breathing, it can warn its user of an impending attack.
17:30 Short talks by academics, industry and startups, Q&A & Networking
18:30 Event closes
If you’re a science, tech or engineering business, academic, start-up or investor using deep tech to improve our world, this event is for you!